Psilocybin Brands
PsiloCare
Psilocybin Brands
Vancouver, British Columbia, Canada
Psilocare psilocybin microdosing products were developed by psychonauts with am appreciation for the mushroom sacrament.
Why Psilocybin?
Research has shown psilocybin to have potential to treat a range of psychiatric and behavioral disorders including:
- Depression: The most researched indications for psilocybin therapy and psilocybin therapy was given “breakthrough therapy” designation by the FDA for depression treatment
- Obsessive-compulsive disorder: A review from neuroethicist Eddie Jacobs in the Journal of Psychedelic Studies suggests psilocybin has potential for treating for obsessive-compulsive disorder (OCD).
- Quitting smoking: researchers found that psilocybin therapy significantly improved abstaining from smoking over a 12-month follow-up period.
- Alcohol addiction: Researchers at the University of Heidelberg treated rat models of alcohol addiction with psilocybin and found that psilocybin staved off cravings.
- Cancer-related/end-of-life psychological distress: A randomized, double-blind trial from Johns Hopkins in 2016 found that a single dose of psilocybin substantially improved quality of life and decreased depression and anxiety in people with life-threatening cancer diagnoses.
PsiloCare Founders
Our first founder was born and raised on the British Columbian coast. He overcame a decade-long battle with substance abuse with the help of micro-dosing combined with macro-dosing.
Our second founder hails from Mexico and has a long-standing history in traditional mushroom healing from a very young age. Together with their collective knowledge, alongside a registered Nutritionist, they developed various blends unique to the micro-dosing community.